Monoclonal antibody
Type Whole antibody
Source Humanized (from rat)
Target EGFR
Clinical data
ATC code none
CAS Number 959963-46-3
ChemSpider none
Chemical and physical data
Formula C6434H9942N1718O2016S44
Molar mass 145.0 kg/mol

Imgatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator.[1][2]

This drug was developed by Genentech/Roche.


  1. World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).
  2. Statement On A Nonproprietary Name Adopted By The USAN Council - Imgatuzumab, American Medical Association.

This article is issued from Wikipedia - version of the 5/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.